Venus Leg Ulcers

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MediWound
MediWoundYAVNE, Israel
1 program
1
EscharExPhase 21 trial
Active Trials
NCT06690177Not Yet Recruiting45Est. Sep 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
MediWoundEscharEx

Clinical Trials (1)

Total enrollment: 45 patients across 1 trials

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Start: Apr 2025Est. completion: Sep 202845 patients
Phase 2Not Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space